X marks the shot against malaria

Raphael A. Reyes, Rolando Garza, Evelien M. Bunnik

Research output: Contribution to journalComment/debatepeer-review


The development of a transmission-blocking vaccine (TBV) against malaria is hampered by poor understanding of functional antibody responses. In this issue of Immunity, Fabra-Garcia et al., Ivanochko et al., and Tang et al. isolate human monoclonal antibodies against the two most promising TBV candidates, Pfs48/45 and Pfs230, and map the epitopes responsible for potent transmission-reducing activity.

Original languageEnglish (US)
Pages (from-to)234-236
Number of pages3
Issue number2
StatePublished - Feb 14 2023

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'X marks the shot against malaria'. Together they form a unique fingerprint.

Cite this